Navigation Links
Reportlinker Adds Wound Care Markets, 4th. Edition, Vol. II: Burns Report
Date:9/22/2009

>

For each segment and subsegment, the report gives current market size and forecasted revenues years 2009 through 2013. Competitive market share information is provided by leading manufacturer for each major segment in the year 2006. Historical data are provided for each of the years 2003 through 2008. The study also details research developments, industry trends, and relevant epidemiologic and demographic data.

Since the last edition of Kalorama Information's Wound Care Markets Series, there have been shifts in the market for treatment of burns. Up-to-date information was obtained from coverage of the world-renown Symposium on Advanced Wound Care and the Wound Healing Society convention. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals and company reports and releases. Key information from published literature was used to conduct interviews with over 62 industry executives and product managers to validate and obtain expert opinion on current and future trends in the wound care industry. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as in formulating market projections.

All market data pertain to the market at the manufacturers' level. Data are expressed in current U.S. dollars.

Marketing directors, product managers, business development executives in the wound care industry, investment specialists considering investments in this area and consultants and advertising agencies who service wound care clients are among those who will find this study a useful resource.

License Note: Kalorama Information's listed default price on its information products reflects a single user license only. Purchasing a departmental or g
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Reportlinker Adds Omega Fatty Acids: Trends in the Worldwide Food and Beverage Markets, 2nd Edition Report
2. Reportlinker Adds Medical Beds and Medical Chairs Report
3. Reportlinker Adds U.S. Equine Market: Feed, Health Care and Services for Horses, The Report
4. Reportlinker Adds World Anti-Obesity Drugs Market Report
5. Reportlinker Adds World Bone Grafts Market Report
6. Reportlinker Adds North America Air Purification Equipment Market Report
7. Reportlinker Adds World Cardiac Biomarkers Market Report
8. Reportlinker Adds World Botulinum Toxin Market Report
9. Reportlinker Adds US Cosmetic Surgery Procedures And Products Market Report
10. Reportlinker Adds US and European Radiopharmaceuticals Market Report
11. Reportlinker Adds World Cancer Therapies Market Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Inc., developers of the AcceleDent System , ... announced Alison Davies as its new Director of ... spent the last fourteen years of her professional ... nine years as a senior manager with ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO ) ,, ...
(Date:12/16/2009)... -- In a random sampling of wood pallets ... Philadelphia, PA, numerous pallets tested positive for Listeria ... potentially create health hazards for consumers. The ... pallet testing conducted in the Washington-Baltimore area, further ... our nation,s food supply from wood pallets. ,, ...
(Date:12/16/2009)... an amino acid typically found in red meats, ... seeds, can possibly increase the risk of developing ... researchers. , The researchers published their findings, titled ... a mouse model of Alzheimer,s disease," in the ... methionine reaches too high a level, our body ...
(Date:12/16/2009)... conducted through national AAD program ,, ... dies from melanoma, the deadliest form of skin ... successfully treated, if caught early. That,s why thousands ... cancer screenings in their communities through the American ... Program. The program recently reached a milestone - ...
(Date:12/16/2009)... Buchanan, owner of Supreme Ultimate Fitness in Boca ... for his students in the new year. The difference with ... their own prize or against each other. They will be ... Humane Society in Boca Raton, FL. ,, "For ... and February 28, 2010 I will donate $10 to the ...
Breaking Medicine News(10 mins):Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 3Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 4Health News:New Tests Confirm Wood Pallets Harbor Deadly Food Poisoning Bacteria 2Health News:New Tests Confirm Wood Pallets Harbor Deadly Food Poisoning Bacteria 3Health News:New Tests Confirm Wood Pallets Harbor Deadly Food Poisoning Bacteria 4Health News:Diet high in methionine could increase risk of Alzheimer's 2Health News:Dermatologists Reach Skin Cancer Screening Milestone 2Health News:Dermatologists Reach Skin Cancer Screening Milestone 3Health News:Fitness Trainer Motivates Clients with Weight Loss to Help Raise Money for Animal Shelter 2
... the risk of getting on fire due to the recent desert ... being worsed by continuous heavy hot desert winds//. Most of the ... the rocket factory which is considered to be highly toxic is ... personnel had a tough time controlling the fire from spreading with ...
... London Queen Mary’s School of Medicine, London has employed ... the gene which is probably responsible for skin cancer//. ... mutations leads to Basal cell carcinoma, which is the ... each year, causing 500 deaths yearly. By using this ...
... cancer is one of the most common forms of cancer ... age, height, obesity, and genetic predisposition have been held responsible ... research conducted has offered insights into the association between obesity ... ages of 25 and 40 are twice as likely to ...
... become very easy and cheap compared to other countries, which ... India. , ,Outsourcing in the field of IT can ... of India, but Outsourcing in // clinical trials is ... source of experimental animals and being exploited., ,Due to ...
... Positron emission tomography (PET) brain scans may help in ... ,According to a study presented at the 130th annual ... // researchers from National Institutes of Neurological Disorders ... marker that shows deficits in signaling for the neurotransmitter ...
... mutation is associated with the neurological disorder called hereditary ... with chronic pains. // , ,HNA episodes are ... overworking the arms and shoulders. Nerve inflammation and changes ... immune response are contributing to the episode. The on ...
Other Medicine News:
(Date:12/16/2009)... MOUNTAIN VIEW, Calif., Dec. 16 ChemoCentryx, ... patients in a Phase 2 clinical trial of ... to specifically target the CCR1 chemokine receptor for ... CCX354 is a highly potent and selective antagonist ... recruitment of immune cells, such as monocytes and ...
(Date:12/16/2009)... , - MIVI-TRUST ... Total of Over,640 patients Ahead of Schedule ... (Euronext Brussels: THR), a biopharmaceutical company,focused on ... for eye,disease, vascular disease and cancer, announces ... the second Phase III trial evaluating microplasmin ...
(Date:12/15/2009)... DIEGO, Dec. 15 Volcano Corporation (Nasdaq: ... intravascular therapy guidance tools - including Fractional Flow ... and Optical Coherence Tomography (OCT) - designed to ... peripheral vascular disease, announced today the placement of ... s5 family of consoles was first launched in ...
Breaking Medicine Technology:ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 2ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 3ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 4ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 5ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 2ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 3ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 4Volcano Announces Installed Base Growth Milestone 2Volcano Announces Installed Base Growth Milestone 3Volcano Announces Installed Base Growth Milestone 4Volcano Announces Installed Base Growth Milestone 5Lumension Webinar to Discuss Key Steps to Harmonize Compliance Controls and Streamline IT Audit Processes with the Unified Compliance Framework 59722 1Lumension Webinar to Discuss Key Steps to Harmonize Compliance Controls and Streamline IT Audit Processes with the Unified Compliance Framework 59722 2Lumension Webinar to Discuss Key Steps to Harmonize Compliance Controls and Streamline IT Audit Processes with the Unified Compliance Framework 59722 3Lumension Webinar to Discuss Key Steps to Harmonize Compliance Controls and Streamline IT Audit Processes with the Unified Compliance Framework 59722 4SourceMedical Launches New Tool to Automate Insurance Eligibility Verification for Ambulatory Surgery Centers 59718 1SourceMedical Launches New Tool to Automate Insurance Eligibility Verification for Ambulatory Surgery Centers 59718 2SourceMedical Launches New Tool to Automate Insurance Eligibility Verification for Ambulatory Surgery Centers 59718 3Athens Consulting Volunteers Time To Habitat For Humanity 59714 1Athens Consulting Volunteers Time To Habitat For Humanity 59714 2
... Novel Heat Shock Protein 90 Inhibitor,Reveal Further ... CAMBRIDGE, Mass. and GAITHERSBURG, Md., June 5, ... and,MedImmune, Inc. (Nasdaq:MEDI) today announced updated interim,results ... the companies' heat shock,protein 90 (Hsp90) inhibitor, ...
... Study Results Show Antibodies Against Cancer-Causing Virus,Types 16 ... Greater Than Natural,Infection Levels, CHICAGO, June 05, 2007 ... 18 months after the first of a three-dose ... vaccinated with the GlaxoSmithKline,(GSK) cervical cancer candidate vaccine ...
Other Medicine Technology:Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 2Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 3Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 4Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 5Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 6Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 7Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides,Sustained Immune Response in 100 Percent of Women up to 55 Years of,Age 2Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides,Sustained Immune Response in 100 Percent of Women up to 55 Years of,Age 3Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides,Sustained Immune Response in 100 Percent of Women up to 55 Years of,Age 4Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides,Sustained Immune Response in 100 Percent of Women up to 55 Years of,Age 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: